Researchers at PhAI Labs have expanded Yann LeCun's JEPA architecture to work across seven fields, from robotics to biomedicine. The effort also produced a liver cancer treatment candidate that showed promise in lab tests, though the study doesn't establish whether it could become an actual therapy.
